Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2536 AL 2550

Narrative Review: Intestinal α-Syn Oligomers as a Novel Pharmacological Target for Parkinson's Disease

Shen Q, Lv A, Li Y, Liu P, Yang J, Wang S, Guo H.

Neurogastroenterol Motil. 2026 Mar;38(3):e70289. doi: 10.1111/nmo.70289.

Interconnected roles of astrocytes and the blood-brain barrier in Parkinson's disease: pathological evidence, mechanistic insights, and knowledge gaps

Stoll AC, Harms AS.

Front Aging Neurosci. 2026 Mar 5;18:1765195. doi: 10.3389/fnagi.2026.1765195. eCollection 2026.

Potential Effects of Music on Non-Motor Symptoms in Parkinson's Disease: Translating Mechanisms to Therapy

Ballmann CG, Schmid DG, Rogers RR, Oakes HK, Osburn SC.

Neurol Int. 2026 Feb 26;18(3):45. doi: 10.3390/neurolint18030045.

Stigma and social symptoms in Parkinson's disease: A scoping review

Gaiera F, O'Shea E, O'Keeffe GW, Doherty M, Timmons S.

Clin Park Relat Disord. 2026 May 6;14:100446. doi: 10.1016/j.prdoa.2026.100446. eCollection 2026.

Overcoming Oxidative Stress in Parkinson's Disease: NADPH Oxidase 4 (NOX4) as a Potential Therapeutic Target

Xu X, Wang Q, Liu Z, Li J, Wang S, Qian L.

Antioxidants (Basel). 2026 May 1;15(5):571. doi: 10.3390/antiox15050571.

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease

Yu Z, Su D, Li S, Lin S, Ren K, Feng T.

Transl Neurodegener. 2026 May 28;15(1):25. doi: 10.1186/s40035-026-00558-0.

Advances in therapeutic hybrid neuromodulation for Parkinson's disease

Bano I, Jeevanandam J, Tsenov G.

3 Biotech. 2026 Jan;16(1):58. doi: 10.1007/s13205-025-04681-z. Epub 2026 Jan 5.

NRF2 at the crossroads of Parkinson's disease and aging: Mechanistic insights and translational perspectives

García-Yagüe AJ, Esteras N, Dinkova-Kostova AT, Rojo AI, Shiels PG, Dinnyes A, Tamas V, van Goor H, Lastres-Becker I.

Free Radic Biol Med. 2026 Mar 16;246:760-779. doi: 10.1016/j.freeradbiomed.2026.01.023. Epub 2026 Jan 13.

Mitochondrial dysfunction and disrupted neuronal lipid homeostasis in Parkinson's disease: Potential mechanisms and therapeutic implications

Quan Z, Ku CY, Xie T, Fok HT, Schweitzer D, Akefe IO.

Exp Neurol. 2026 Jun;400:115703. doi: 10.1016/j.expneurol.2026.115703. Epub 2026 Feb 26.

Circadian disruption and its clinical implications in Parkinson's disease: A Narrative review

Kataoka H, Saeki K, Sugie K, Obayashi K.

Sleep Med. 2026 Jul;143:108928. doi: 10.1016/j.sleep.2026.108928. Epub 2026 Mar 25.

Exercise suppresses apoptosis for alleviating Parkinson's disease: effects on pathophysiological molecular pathways

Chen J, Liu X, Wu Y, Wang C, Wang C.

Front Aging Neurosci. 2026 Mar 27;18:1810397. doi: 10.3389/fnagi.2026.1810397. eCollection 2026.

Reimagining the contribution of iron in Parkinson's disease

Serpa RO, Tufano E, Connor JR.

Neurobiol Dis. 2026 May 5;225:107434. doi: 10.1016/j.nbd.2026.107434. Online ahead of print.

Purinergic modulation in Parkinson's disease: the dual role of istradefylline in motor and cognitive outcomes

Rejili M, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Jabir MS, Shokr MM, Batiha GE.

Purinergic Signal. 2026 May 14;22(3):49. doi: 10.1007/s11302-026-10160-8.

Nonmotor Symptoms in Parkinson's Disease: Neurophysiology Biomarkers and Neuromodulation Approaches

Pathak N, Chen R, Chao A, Bick SK.

Stereotact Funct Neurosurg. 2026 May 21:1-14. doi: 10.1159/000551492. Online ahead of print.

Quantitative and Comparative Analysis of Dream Content in Parkinson's Disease Patients Undergoing Deep Brain Stimulation: A Pilot Study

Joswig H, Oreizi-Esfahani S, Medack S, Träger U, Staudt MD.

World Neurosurg. 2026 Mar;207:124816. doi: 10.1016/j.wneu.2026.124816. Epub 2026 Jan 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias